Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.11 | 14.29 |
| PEG Ratio (TTM) | -0.06 | -4.45 |
| P/S Ratio (TTM) | 0.23 | 2.12 |
| P/B Ratio (TTM) | 0.61 | 5.90 |
| P/FCF Ratio (TTM) | -1.66 | 20.92 |
| Price to 5YR AVG Earnings Ratio | -0.67 | 25.53 |
| Price to 5YR AVG FCF Ratio | -1.74 | 28.53 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -18.23% | 9.06% |
| ROE (TTM) | -48.88% | 39.24% |
| Net Profit Margin (TTM) | -19.88% | 13.47% |
| ROIC 5YR AVG | -56.22% | 14.81% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 13.73% | -14.58% | -143.38% |
| Revenue | -0.09% | 55.95% | 36.50% |
| Net Income | 11.67% | -19.60% | -156.74% |
| Cash Flow | 5.81% | 0.69% | -138.71% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.94 | 2.33 |
| Quick Ratio (TTM) | 0.93 | 1.85 |
| D/E Ratio (TTM) | 0.13 | 2.09 |
| Interest Coverage (TTM) | -38.80 | 13.63 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | N/A | 3.39 |
| LTL to 5YR AVG FCF | -0.21 | 7.29 |
| Shares Outstanding Growth 5YR AVG | 25.78% | -2.05% |